Travis Lim

2.3k total citations
37 papers, 816 citations indexed

About

Travis Lim is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Travis Lim has authored 37 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Travis Lim's work include HIV/AIDS Research and Interventions (13 papers), Viral Infections and Immunology Research (9 papers) and Global Maternal and Child Health (6 papers). Travis Lim is often cited by papers focused on HIV/AIDS Research and Interventions (13 papers), Viral Infections and Immunology Research (9 papers) and Global Maternal and Child Health (6 papers). Travis Lim collaborates with scholars based in United States, Canada and Uganda. Travis Lim's co-authors include Decheng Yang, Yuan Ji, Alhousseynou Sall, Lijing Han, Huifang Zhang, Wayne S. Sossin, Zhen Liu, David Chau, Zhen Liu and Yue Su and has published in prestigious journals such as The Lancet, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Travis Lim

32 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Travis Lim United States 15 275 262 214 175 119 37 816
Norma Pérez United States 17 389 1.4× 64 0.2× 87 0.4× 255 1.5× 432 3.6× 40 1.1k
Curtis Yeager United States 7 175 0.6× 477 1.8× 32 0.1× 198 1.1× 126 1.1× 10 1.0k
Ruth Watkinson United Kingdom 17 362 1.3× 247 0.9× 63 0.3× 80 0.5× 317 2.7× 26 1.2k
Pedro Martı́nez Cuba 16 94 0.3× 109 0.4× 53 0.2× 226 1.3× 259 2.2× 47 776
Andrew K. Hastings United States 21 186 0.7× 622 2.4× 44 0.2× 497 2.8× 458 3.8× 28 1.3k
Christine Laurent France 12 208 0.8× 382 1.5× 24 0.1× 138 0.8× 172 1.4× 16 734
Hongwei Jia United States 20 191 0.7× 197 0.8× 44 0.2× 102 0.6× 237 2.0× 36 1.1k
Suzanne M. Scheaffer United States 16 277 1.0× 447 1.7× 28 0.1× 587 3.4× 274 2.3× 23 1.3k
Hilda N. Rivera United States 19 290 1.1× 104 0.4× 26 0.1× 245 1.4× 355 3.0× 30 997
Richard D. Henkel United States 15 352 1.3× 138 0.5× 152 0.7× 113 0.6× 270 2.3× 30 1.1k

Countries citing papers authored by Travis Lim

Since Specialization
Citations

This map shows the geographic impact of Travis Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travis Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travis Lim more than expected).

Fields of papers citing papers by Travis Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Travis Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travis Lim. The network helps show where Travis Lim may publish in the future.

Co-authorship network of co-authors of Travis Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Travis Lim. A scholar is included among the top collaborators of Travis Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Travis Lim. Travis Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Suying, Mary J. Christoph, Haifeng Guo, et al.. (2025). Treatment Persistence and Switch Among Medicare-Insured People with HIV and Gaps in Care. Infectious Diseases and Therapy. 15(1). 117–132.
2.
Moyle, Graeme, Andrea Marongiu, Paul E. Sax, et al.. (2025). Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption. AIDS. 39(9). 1125–1132. 1 indexed citations
3.
Dieterich, Douglas T., Laurence Brunet, Karam Mounzer, et al.. (2025). Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B. AIDS. 40(1). 43–51.
4.
Mounzer, Karam, Laurence Brunet, Gerald Pierone, et al.. (2025). Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide. AIDS Research and Therapy. 22(1). 71–71.
5.
Lim, Travis, et al.. (2020). HIV Policy Advancements in PEPFAR Partner countries: a review of data from 2010–2016. Global Public Health. 16(3). 390–400. 4 indexed citations
6.
Stover, Bert, Travis Lim, Frederick Makumbi, et al.. (2016). Did PEPFAR investments result in health system strengthening? A retrospective longitudinal study measuring non-HIV health service utilization at the district level. Health Policy and Planning. 31(7). 897–909. 27 indexed citations
7.
McNairy, Margaret L., Charon Gwynn, Miriam Rabkin, et al.. (2016). Increased utilisation of PEPFAR-supported laboratory services by non-HIV patients in Tanzania. African Journal of Laboratory Medicine. 5(1). 1 indexed citations
8.
Hanson, Paul, Ye Qiu, Maged Gomaa Hemida, et al.. (2015). Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes. Cell Death and Differentiation. 23(5). 828–840. 28 indexed citations
9.
Lim, Travis, Constantine Frangakis, Carl A. Latkin, et al.. (2014). Community-Level Income Inequality and HIV Prevalence among Persons Who Inject Drugs in Thai Nguyen, Vietnam. PLoS ONE. 9(3). e90723–e90723. 17 indexed citations
10.
Lim, Travis, Carla E. Zelaya, Carl A. Latkin, et al.. (2013). Individual‐level socioeconomic status and community‐level inequality as determinants of stigma towards persons living with HIV who inject drugs in Thai Nguyen, Vietnam. Journal of the International AIDS Society. 16(3S2). 18637–18637. 37 indexed citations
11.
Li, Quan, Diancai Cai, Ann E. Fink, et al.. (2009). Role of Protein Kinase C in the Induction and Maintenance of Serotonin-Dependent Enhancement of the Glutamate Response in Isolated Siphon Motor Neurons ofAplysia californica. Journal of Neuroscience. 29(16). 5100–5107. 42 indexed citations
12.
Lim, Travis, Carole A. Farah, Varsha Manjunath, et al.. (2009). The atypical protein kinase C in Aplysia can form a protein kinase M by cleavage. Journal of Neurochemistry. 109(4). 1129–1143. 60 indexed citations
13.
Zhang, Huifang M., Yue Su, Songchuan Guo, et al.. (2009). Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs. Antiviral Research. 83(3). 307–316. 35 indexed citations
14.
Sall, Alhousseynou, Huifang M. Zhang, Dexin Qiu, et al.. (2009). Pro-apoptotic activity of mBNIP-21 depends on its BNIP-2 and Cdc42GAP homology (BCH) domain and is enhanced by coxsackievirus B3 infection. Cellular Microbiology. 12(5). 599–614. 11 indexed citations
15.
Lim, Travis. (2008). Antisense DNA and RNA agents against picornaviruses. Frontiers in bioscience. Volume(13). 4707–4707. 5 indexed citations
16.
Yang, Decheng, et al.. (2008). MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases. Current Drug Discovery Technologies. 5(1). 49–58. 22 indexed citations
17.
18.
Lim, Travis & Wayne S. Sossin. (2006). Phosphorylation at the hydrophobic site of protein kinase C Apl II is increased during intermediate term facilitation. Neuroscience. 141(1). 277–285. 10 indexed citations
19.
Chau, David, Yuan Ji, Huifang Zhang, et al.. (2006). Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. APOPTOSIS. 12(3). 513–524. 114 indexed citations
20.
Lim, Travis, et al.. (1980). Dengue hemorrhagic fever in Malaysia: the 1973 epidemic.. PubMed. 11(1). 1–13. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norma Pérez Breakdown of academic impact, for papers by Curtis Yeager Breakdown of academic impact, for papers by Ruth Watkinson Breakdown of academic impact, for papers by Pedro Martı́nez Breakdown of academic impact, for papers by Andrew K. Hastings Breakdown of academic impact, for papers by Christine Laurent Breakdown of academic impact, for papers by Hongwei Jia Breakdown of academic impact, for papers by Suzanne M. Scheaffer Breakdown of academic impact, for papers by Hilda N. Rivera Breakdown of academic impact, for papers by Richard D. Henkel
Rankless by CCL
2026